Investor Class Certified On Claims Pfizer Masked Drug Risks

Law360, New York (March 30, 2012, 4:52 PM EDT) -- A New York federal judge on Thursday certified a class of Pfizer Inc. investors accusing the pharmaceutical giant of securities fraud for allegedly concealing studies showing the heart attack risks linked to arthritis drugs Celebrex and Bextra.

U.S. District Judge Laura Taylor Swain said the plaintiffs, a class of investors who had bought Pfizer stock between October 2000 and October 2005, had adequately shown that there were questions of law and fact common to the class and that the class representative’s claims are typical of those...
To view the full article, register now.




Case Information

Case Title

In Re: Pfizer Securities Litigation

Case Number



New York Southern

Nature of Suit



Laura Taylor Swain

Date Filed

December 15, 2004

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.